Polygon Management Ltd.
13F Reported Value
ⓘ$515.1M
incl. option notional
Equity Holdings
ⓘ$508.9M
Option Notional
ⓘ$6.2M
$0 puts / $6.2M calls
Holdings
36
Latest Filing
2026-03-31
Filing Quarter
Q1 2026
Portfolio Overview
Polygon Management Ltd. disclosed 36 positions worth $515.1M in its Form 13F-HR for Q1 2026 — $508.9M in common stock plus $6.2M of put/call option positions (reported at underlying notional value, not premium at risk), led by $PATH (UiPath, Inc.) at 55.0% of the equity portfolio, followed by $KGEI and $WBD. During the quarter the fund opened 12 new positions and exited 4 — including a new stake in $WBD and a full exit from $RAPT. The portfolio is most concentrated in Technology (60.8% of disclosed assets). All figures are sourced directly from Polygon Management Ltd.’s Form 13F-HR filing with the SEC under CIK 1515070.
AI Fund Analysis
DiversifyingSector Allocation
AUM History
Top Equity Holdings by Value
Option Positions
13F rules report options at the value of the underlying shares (notional) — not the premium paid or capital at risk. Shown separately from the equity sleeve above.
Quarterly Activity — Q1 2026
Click any card to unlockTop Holdings
- 67.7#451
Quality
$279.8M25,207,628 sh - —
Quality
$37.5M6,834,504 sh - 42.1#1,870
Quality
$25.4M923,725 sh - 52.8
Quality
$14.9M250,000 sh - 63.1
Quality
$13.3M1,000,000 sh - 51.3
Quality
$13.2M2,200,000 sh - —
Quality
$13.1M9,500,000 sh - 13.2
Quality
$9.9M312,316 sh - 74.4
Quality
$8.0M127,198 sh - 10.2
Quality
$7.4M103,037 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 UiPath, Inc.$PATH | 67.7#451 | $279.8M | 25,207,628 |
 Kolibri Global Energy Inc.$KGEI | — | $37.5M | 6,834,504 |
 Warner Bros. Discovery, Inc.$WBD | 42.1#1,870 | $25.4M | 923,725 |
 WORKIVA INC$WK | 52.8 | $14.9M | 250,000 |
 Lyft, Inc.$LYFT | 63.1 | $13.3M | 1,000,000 |
 Sprinklr, Inc.$CXM | 51.3 | $13.2M | 2,200,000 |
 Autolus Therapeutics plc$AUTL | — | $13.1M | 9,500,000 |
 Celldex Therapeutics, Inc.$CLDX | 13.2 | $9.9M | 312,316 |
 ARROWHEAD PHARMACEUTICALS, INC.$ARWR | 74.4 | $8.0M | 127,198 |
 NEKTAR THERAPEUTICS$NKTR | 10.2 | $7.4M | 103,037 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of Polygon Management Ltd.'s 36 positions.
Showing top 10 of 36 holdings.
Sector Allocation
Technology
$309.4M
Healthcare
$123.3M
Energy
$37.5M
Communication Services
$25.4M
Industrials
$13.3M
Full Holdings — Polygon Management Ltd. (Q1 2026)
All 36 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $PATH | UiPath, Inc. | $279.8M | 55.0% | +44% | 67.7 |
| 2 | $KGEI | Kolibri Global Energy Inc. | $37.5M | 7.4% | -1% | — |
| 3 | $WBD | Warner Bros. Discovery, Inc. | $25.4M | 5.0% | NEW | 42.1 |
| 4 | $WK | WORKIVA INC | $14.9M | 2.9% | +67% | 52.8 |
| 5 | $LYFT | Lyft, Inc. | $13.3M | 2.6% | +0% | 63.1 |
| 6 | $CXM | Sprinklr, Inc. | $13.2M | 2.6% | +0% | 51.3 |
| 7 | $AUTL | Autolus Therapeutics plc | $13.1M | 2.6% | +0% | — |
| 8 | $CLDX | Celldex Therapeutics, Inc. | $9.9M | 1.9% | +28% | 13.2 |
| 9 | $ARWR | ARROWHEAD PHARMACEUTICALS, INC. | $8.0M | 1.6% | +31% | 74.4 |
| 10 | $NKTR | NEKTAR THERAPEUTICS | $7.4M | 1.5% | +49% | 10.2 |
| 11 |  $ANNX | Annexon, Inc. | $7.2M | 1.4% | -36% | — |
| 12 |  $PHVS | Pharvaris N.V. | $6.3M | 1.2% | +14% | — |
| 13 |  $AXSMCALL | Axsome Therapeutics, Inc. | $5.9M | — | NEW | 36.6 |
| 14 |  $ALKS | Alkermes plc. | $5.7M | 1.1% | +13% | — |
| 15 |  $AGIO | AGIOS PHARMACEUTICALS, INC. | $5.6M | 1.1% | +2% | 26.3 |
| 16 |  $IMVT | Immunovant, Inc. | $5.4M | 1.1% | +31% | — |
| 17 |  $PRAX | Praxis Precision Medicines, Inc. | $5.1M | 1.0% | -30% | — |
| 18 |  $KRYS | Krystal Biotech, Inc. | $5.1M | 1.0% | +66% | 75.9 |
| 19 |  $DYN | Dyne Therapeutics, Inc. | $4.7M | 0.9% | +4% | — |
| 20 |  $AMLX | Amylyx Pharmaceuticals, Inc. | $4.4M | 0.9% | +17% | — |
| 21 |  $MBX | MBX Biosciences, Inc. | $4.3M | 0.8% | +2% | — |
| 22 |  $DFTX | Definium Therapeutics, Inc. | $3.8M | 0.7% | NEW | — |
| 23 |  $SLNO | SOLENO THERAPEUTICS INC | $3.4M | 0.7% | NEW | 46.3 |
| 24 | $AXSM | Axsome Therapeutics, Inc. | $3.4M | 0.7% | -26% | 36.6 |
| 25 |  $HRMY | Harmony Biosciences Holdings, Inc. | $3.3M | 0.7% | +44% | 75.3 |
| 26 |  $SLN | Silence Therapeutics plc | $3.3M | 0.7% | +72% | — |
| 27 |  $ACAD | ACADIA PHARMACEUTICALS INC | $3.2M | 0.6% | NEW | 69.8 |
| 28 |  $IONS | IONIS PHARMACEUTICALS INC | $3.1M | 0.6% | NEW | 37.1 |
| 29 |  $MPLT | MapLight Therapeutics, Inc. | $2.3M | 0.5% | -32% | — |
| 30 |  $RLAY | Relay Therapeutics, Inc. | $1.8M | 0.3% | NEW | 12.7 |
| 31 |  $SNOW | Snowflake Inc. | $1.5M | 0.3% | +0% | 49.6 |
| 32 |  $AARD | Aardvark Therapeutics, Inc. | $1.2M | 0.2% | NEW | — |
| 33 |  $TECX | Tectonic Therapeutic, Inc. | $1.2M | 0.2% | NEW | — |
| 34 |  $RARE | Ultragenyx Pharmaceutical Inc. | $826,959 | 0.2% | NEW | 31 |
| 35 |  $KPTI | Karyopharm Therapeutics Inc. | $295,121 | 0.1% | NEW | 20.4 |
| 36 | $KPTICALL | Karyopharm Therapeutics Inc. | $278,500 | — | NEW | 20.4 |
New Positions (12)
$WBD Warner Bros. Discovery, Inc.$25.4M$AXSMCALL Axsome Therapeutics, Inc.$5.9M$DFTX Definium Therapeutics, Inc.$3.8M$SLNO SOLENO THERAPEUTICS INC$3.4M$ACAD ACADIA PHARMACEUTICALS INC$3.2M$IONS IONIS PHARMACEUTICALS INC$3.1M$RLAY Relay Therapeutics, Inc.$1.8M$AARD Aardvark Therapeutics, Inc.$1.2M$TECX Tectonic Therapeutic, Inc.$1.2M$RARE Ultragenyx Pharmaceutical Inc.$826,959$KPTI Karyopharm Therapeutics Inc.$295,121$KPTICALL Karyopharm Therapeutics Inc.$278,500
Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for Polygon Management Ltd. including:
Track Polygon Management Ltd.'s Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for Polygon Management Ltd. and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: Polygon Management Ltd.
13F Pro is an AI hedge fund tracker and stock research platform. For Polygon Management Ltd. (SEC CIK: 1515070), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Polygon Management Ltd.'s portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.